NM heute noch unter 1100 und morgen ...

bzw. am Montag unter 1000 ...
das nennt man auch galoppierente Schwinsucht ...
lol

haut weg dire Scheisse ... alles muss raus ..
ob ihr wollt oder nicht ...

solong best invest

Nmt Medical Inc. (MM (NASDAQ:NMTI)
Last Price (USD) $0.7693
Change  0.0405 (5.56%)
Bid 0.7651
Ask 0.7691
Volume 1,451,707
Days Range 0.74 - 0.8282
Last Trade 6/21/2010 11:50:25 AM

sieht aus als ob wir die Rakete heute gg. ne Konso eintauschen ...naja, alles zu seiner Zeit ;).

lesen..mit Intraday chart !

investorshub.advfn.com/boards/read_msg.aspx?message_id=51540061

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

investorshub.advfn.com/boards/read_msg.aspx?message_id=51540801

investorshub.advfn.com/boards/...id=51554168&txt2find=nmti

Yes just as you posted i was reading the 13G and watched if its listed at www.insidercow.com
Sellers should be out now. IMO !



S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 341,938 $0.69 $236,963.00 1,127,420 view
S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 240,000 $0.65 $156,000.00 1,469,360 view
S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 400,000 $0.68 $271,760.00 1,709,360 view
S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 500,000 $0.76 $382,300.00 2,109,360 view

Looks like they are done...

Glenhill Capital, LP

(d) The Reporting Persons no longer own any Common Stock of the Issuer.

ih.advfn.com/p.php?pid=nmona&article=43343166


June 18, 2010 Sold 239,940

191,900

115,200

479,700

164,138 $0.7646

$0.6794

$0.6500

$0.7126

$0.6930

Glenhill Concentrated Long Master Fund, LLC June 18, 2010 Sold 47,300

37,900

22,700

94,700

32,400 $0.7646

$0.6794

$0.6500

$0.7126

$0.6930

Glenhill Capital Overseas Master Fund, LP June 18, 2010 Sold 212,760

170,200

102,100

425,600

145,400
$0.7646

$0.6794

$0.6500

$0.7126

$0.6930

Glenn J. Krevlin June 18, 2010 Sold 118,420 $0.7110

Glenn J. Krevlin June 21, 2010 Sold 300

8,700 $0.8001

$0.8000



(d) The Reporting Persons no longer own any Common Stock of the Issuer.

Afterhours 0.74$  da tut sich was. :-)

investorshub.advfn.com/boards/read_msg.aspx?message_id=51675563

Posted by: jaybird249    Date: Thursday, June 24, 2010 3:23:24 PM  
In reply to: None  Post # of 1888288      

NMTI:NASDAQ green, double bottom in. Going to explode to $1 ++
finance.yahoo.com/...s?s=NMTI+Interactive#symbol=NMTI;range=5d

NMTI declined 400% last week, an absurd overreaction to PRELIMINARY results that were OVERALL POSITIVE:

-STARFlex provided SMALL BENEFIT OVER CURRENT BEST MEDICAL THERAPY and maintained an excellent safety profile. NMTI is discussing next steps with the FDA.

Other useful DD and links:

-NMTI dramatically oversold:
messages.finance.yahoo.com/Stocks...

-55% of float owned by institutions. "Available float" only 7 million shares.

-Insiders have purchased over 800,000 shares at prices over $2 in last 6 months.

-The most successful U.S. hedge fund- Renaissance Technololgies, owns NMTI. Renaissance has an army of engineers and MBA's scouring for undervalued stocks.

-In may, the NMTI RT2 Delivery System was lauched in France and will be launched all throughout Europe over the next few months.
finance.yahoo.com/news/NMT-Medica...

-NMTI Owns or licenses 136 patents, relating to structural heart repair implant technologies and other related cardiovascular implant technologies.

:-)

mcaaron.files.wordpress.com/2009/10/bounce.jpg" style="max-width:560px" />

und bis weihnachten auch wieder über 1 US$

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

investorshub.advfn.com/boards/read_msg.aspx?message_id=58169748

www.mysmartrend.com/news-briefs/...ard-momentum-shares-nmt-med

SmarTrend's Trend Spotter See Continued Upward Momentum on Shares of NMT Medical (NMTI)
Written on Mon, 01/03/2011 - 10:03am
By Chip Brian

SmarTrend is monitoring the recent change of momentum in NMT Medical. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of NMT Medical in search of a potential trend change.
In the past 52 weeks, shares of NMT Medical have traded between a low of $0.20 and a high of $4.99 and are now at $0.42, which is 109% above that low price.
NMT Medical is currently above its 50-day moving average of $0.28 and should find resistance at its 200-day moving average of $1.43. Look for these moving averages to climb to confirm the company's upward momentum.
In the last five trading sessions, the 50-day MA has fallen 0.56% while the 200-day MA has slid 5.21%.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of NMT Medical shares.

NMT Medical Announces New $2 Million Credit Facility

Date : 01/06/2011 @ 7:30AM
Source : MarketWire
Stock : NMT Medical (NMTI)

ih.advfn.com/p.php?pid=nmona&article=45903874

NMT Medical, Inc. (NASDAQ: NMTI) today announced that it has entered into a credit agreement with LSQ Funding Group, L.C., a Florida-based firm that specializes in providing financing to small- and medium-sized businesses.

The asset-based credit facility provides for borrowings up to $2 million for working capital requirements and other general corporate purposes. The credit facility has a one-year term and is subject to a borrowing base calculated as a percentage of domestic accounts receivable that are pledged as collateral against the loan.

Richard E. Davis, NMT's Chairman, President and Chief Executive Officer, said, "This non-equity based credit facility, which replaces the credit arrangement with Silicon Valley Bank that we recently terminated, provides NMT with the necessary working capital required to fund its ongoing operations. We continue to tightly manage our expenses while working closely with the U.S. Food and Drug Administration to evaluate our potential next steps relating to patent foramen ovale (PFO) treatment for the stroke and transient ischemic attack (TIA) indications. In addition, we are continuing to evaluate all strategic options."

http://www.ariva.de/_t72764?pnr=9400082#jump9400082

0.9 schon mal um die "Ecke"